1-10 of 10
Viggo F Van Tendeloo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Clinical Trials & Observations
Sébastien Anguille, Ann L. Van de Velde, Evelien L. Smits, Viggo F. Van Tendeloo, Gunnar Juliusson, Nathalie Cools, Griet Nijs, Barbara Stein, Eva Lion, Ann Van Driessche, Irma Vandenbosch, Anke Verlinden, Alain P. Gadisseur, Wilfried A. Schroyens, Ludo Muylle, Katrien Vermeulen, Marie-Berthe Maes, Kathleen Deiteren, Ronald Malfait, Emma Gostick, Martin Lammens, Marie M. Couttenye, Philippe Jorens, Herman Goossens, David A. Price, Kristin Ladell, Yoshihiro Oka, Fumihiro Fujiki, Yusuke Oji, Haruo Sugiyama, Zwi N. Berneman
Journal: Blood
Blood (2017) 130 (15): 1713–1721.
https://doi.org/10.1182/blood-2017-04-780155
Published: 2017
Includes: Supplemental data
Journal Articles

Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of Clinical Outcome in 66 Cancer Patients

Zwi N. Berneman, Ann L. Van de Velde, Yannick Willemen, Sébastien Anguille, Kirsten Saevels, Paul Germonpré, Manon T. Huizing, Marc Peeters, Annemie Snoeckx, Paul Parizel, Viggo F Van Tendeloo, Eva Lion, Griet Nijs, Barbara Stein, Katrien Vermeulen, Marie-Berthe Maes, Ronald Malfait, Inge Vrelust, Anke Verlinden, Alain P. Gadisseur, Wilfried A Schroyens, Martin Lammens, Evelien L. Smits
Journal: Blood
Blood (2014) 124 (21): 310.
https://doi.org/10.1182/blood.V124.21.310.310
Published: 2014
Journal Articles

Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients

Ann L. Van de Velde, Sébastien Anguille, Philippe Beutels, PhD, Suzy Dom, Ingrid Cornille, Griet Nijs, Viggo F Van Tendeloo, Evelien L. Smits, Anke Verlinden, Alain P. Gadisseur, Wilfried A Schroyens, Zwi N Berneman, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1322.
https://doi.org/10.1182/blood.V124.21.1322.1322
Published: 2014
Journal Articles

Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients

Zwi N. Berneman, MD, PhD, FRCP, Ann Van de Velde, MD, Sébastien Anguille, MD, Yannick Willemen, MD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, Griet Nijs, MT, Barbara Stein, MSc, Nathalie Cools, PhD, Ronald Malfait, MD, Marie-Berthe Maes, PharmD, PhD, Katrien Vermeulen, PhD, Viggo F. Van Tendeloo, PhD, Evelien L. Smits, PhD
Journal: Blood
Blood (2013) 122 (21): 236.
https://doi.org/10.1182/blood.V122.21.236.236
Published: 2013
Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Zwi N. Berneman, MD, PhD, Ann an de Velde, MD, Sébastien Anguille, MD, Nathalie Cools, PhD, Ann Van Driessche, MSc, Katrien Vermeulen, PhD, Katrien Pieters, PhD, Griet Nijs, MT, Barbara Stein, MSc, Evelien L. Smits, PhD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, I. Jolanda de Vries, PhD, Kristin Ladell, PhD, Emma Gostick, PhD, David A. Price, MD, PhD, Yusuke Oji, MD, PhD, Yoshihiro Oka, MD, PhD, Haruo Sugiyama, MD, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2010) 116 (21): 16.
https://doi.org/10.1182/blood.V116.21.16.16
Published: 2010
Journal Articles

Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms’ Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia

Zwi N. Berneman, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Viggo F. Van Tendeloo
Journal: Blood
Blood (2008) 112 (11): 830.
https://doi.org/10.1182/blood.V112.11.830.830
Published: 2008
Journal Articles

Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms’ Tumor Protein WT1: A Phase I/II Trial.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, M.Sc., Ann Van de Velde, M.D., Griet Nijs, M.T., Tessa Braeckman, M.Sc., Barbara Stein, M.Sc, Katrien Vermeulen, Ph.D., Katrien Pieters, Ph.D., Alain P. Gadisseur, M.D., Ph.D, Wilfried A. Schroyens, M.D., Ph.D., I. Jolanda de Vries, Ph.D., David A. Price, Ph.D., Viggo F. Van Tendeloo, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 158.
https://doi.org/10.1182/blood.V110.11.158.158
Published: 2007
Journal Articles

Efficient Non-Viral Transfection of Mouse and Human Embryonic Stem Cells.

Zwi N. Berneman, MD, PhD, Jeremy P. Brown, MD, PhD, Sjaak Van der Sar, BSc, Dave Van den Plas, PhD, Lena Van den Eeden, BSc, Dirk R. Van Bockstaele, PhD, Philippe G. Jorens, MD, PhD, Viggo F. Van Tendeloo, PhD, Joseph Merregaert, PhD, Prim B. Singh, PhD, Peter Ponsaerts, PhD
Journal: Blood
Blood (2004) 104 (11): 5267.
https://doi.org/10.1182/blood.V104.11.5267.5267
Published: 2004
Journal Articles

Immunotargetting of the Wilms’ Tumor WT1 Antigen for Dendritic Cell and B-Cell-Based Vaccination of Leukemia.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, BSc, Peter Ponsaerts, PhD, Liquan Gao, MD, Hans J. Stauss, MD, PhD, Wilfried A. Schroyens, MD, PhD, Ann Van de Velde, MD, Alain Gadisseur, MD, Marc Lenjou, MT, Griet Nijs, MT, Dirk R. Van Bockstaele, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2004) 104 (11): 2541.
https://doi.org/10.1182/blood.V104.11.2541.2541
Published: 2004
Journal Articles

RNA Electroporation as a New Gene Transfer Method in Hematopoietic Progenitor Cells, Mesenchymal Cells and Activated T-Cells.

Zwi N. Berneman, MD, PhD, Evelien Smits, BSc, Peter Ponsaerts, PhD, Marc Lenjou, MT, Griet Nijs, MT, Dirk R. Van Bockstaele, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2004) 104 (11): 5269.
https://doi.org/10.1182/blood.V104.11.5269.5269
Published: 2004